505 related articles for article (PubMed ID: 28056730)
1. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.
Jain N; Jaiswal J; Pathak A; Singour PK
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea.
Kashaw SK; Kashaw V; Mishra P; Jain NK; Stables JP
Eur J Med Chem; 2009 Nov; 44(11):4335-43. PubMed ID: 19674817
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.
Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS
Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080
[TBL] [Abstract][Full Text] [Related]
4. Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives.
Saravanan G; Panneerselvam T; Alagarsamy V; Kunjiappan S; Parasuraman P; Murugan I; Dinesh Kumar P
Drug Dev Res; 2018 Sep; 79(6):260-274. PubMed ID: 30244475
[TBL] [Abstract][Full Text] [Related]
5. Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl) phenyl) quinazolin-4(3H)-ones as NMDA receptor inhibitor.
Saravanan G; Panneerselvam T; Kunjiappan S; Parasuraman P; Alagarsamy V; Udayakumar P; Soundararajan M; Joshi SD; Ramalingam S; Ammunje DN
Drug Dev Res; 2019 May; 80(3):368-385. PubMed ID: 30609096
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vivo and in silico evaluation of novel 2,3-dihydroquinazolin-4(1H)-one derivatives as potential anticonvulsant agents.
Kothayer H; Ibrahim SM; Soltan MK; Rezq S; Mahmoud SS
Drug Dev Res; 2019 May; 80(3):343-352. PubMed ID: 30565722
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Anticonvulsant Activity, and SAR Study of Novel 4-Quinazolinone Derivatives.
Noureldin NA; Kothayer H; Lashine EM; Baraka MM; El-Eraky W; Awdan SA
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28177550
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents.
Amir M; Ali I; Hassan MZ
Arch Pharm Res; 2013 Jan; 36(1):61-8. PubMed ID: 23325491
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, anticonvulsant evaluation and docking study of 2-[(6-substituted benzo[d]thiazol-2-ylcarbamoyl)methyl]-1-(4-substituted phenyl)isothioureas.
Siddiqui N; Alam MS; Sahu M; Naim MJ; Yar MS; Alam O
Bioorg Chem; 2017 Apr; 71():230-243. PubMed ID: 28238402
[TBL] [Abstract][Full Text] [Related]
10. Microwave Assisted Synthesis and Molecular Docking Studies of Some 4- (3H)-quinazolinone Derivatives as Inhibitors of Human Gamma- Aminobutyric Acid Receptor, the GABA (A)R-BETA3 Homopentamer.
Amrutkar RD; Ranawat MS
Med Chem; 2021; 17(5):453-461. PubMed ID: 31840612
[TBL] [Abstract][Full Text] [Related]
11. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstituted benzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)phenyl) semicarbazide derivatives.
Saravanan G; Alagarsamy V; Prakash CR
Bioorg Med Chem Lett; 2012 May; 22(9):3072-8. PubMed ID: 22487180
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives.
Pele R; Marc G; Mogoșan C; Apan A; Ionuț I; Tiperciuc B; Moldovan C; Araniciu C; Oniga I; Pîrnău A; Vlase L; Oniga O
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731442
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies.
Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P
Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600
[TBL] [Abstract][Full Text] [Related]
15. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
Ugale VG; Bari SB
Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABA
Wang S; Liu H; Lei K; Li G; Li J; Wei Y; Wang X; Liu R
Bioorg Chem; 2020 Oct; 103():104182. PubMed ID: 32890992
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.
Zayed MF; Ihmaid SK; Ahmed HE; El-Adl K; Asiri AM; Omar AM
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125041
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents.
Mishra CB; Kumari S; Tiwari M
Arch Pharm Res; 2016 May; 39(5):603-17. PubMed ID: 26891908
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.
Abuelizz HA; Dib RE; Marzouk M; Anouar EH; A Maklad Y; N Attia H; Al-Salahi R
Molecules; 2017 Jun; 22(7):. PubMed ID: 28665338
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
Zhang HJ; Jin P; Wang SB; Li FN; Guan LP; Quan ZS
Arch Pharm (Weinheim); 2015 Aug; 348(8):564-74. PubMed ID: 26053879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
